Interleukin-33 in the human placenta

J Matern Fetal Neonatal Med. 2013 Mar;26(4):327-38. doi: 10.3109/14767058.2012.735724. Epub 2012 Nov 23.

Abstract

Objective: Interleukin-33 (IL-33) is the newest member of the IL-1 cytokine family, a group of key regulators of inflammation. The purpose of this study was to determine whether IL-33 is expressed in the human placenta and to investigate its expression in the context of acute and chronic chorioamnionitis.

Methods: Placental tissues were obtained from five groups of patients: 1) normal pregnancy at term without labor (n = 10); 2) normal pregnancy at term in labor (n = 10); 3) preterm labor without inflammation (n = 10); 4) preterm labor with acute chorioamnionitis and funisitis (n = 10); and 5) preterm labor with chronic chorioamnionitis (n = 10). Immunostaining was performed to determine IL-33 protein expression patterns in the placental disk, chorioamniotic membranes, and umbilical cord. mRNA expression of IL-33 and its receptor IL1RL1 (ST2) was measured in primary amnion epithelial and mesenchymal cells (AECs and AMCs, n = 4) and human umbilical vein endothelial cells (HUVECs, n = 4) treated with IL-1β (1 and 10 ng/ml) and CXCL10 (0.5 and 1 or 5 ng/ml).

Results: 1) Nuclear IL-33 expression was found in endothelial and smooth muscle cells in the placenta, chorioamniotic membranes, and umbilical cord; 2) IL-33 was detected in the nucleus of CD14+ macrophages in the chorioamniotic membranes, chorionic plate, and umbilical cord, and in the cytoplasm of myofibroblasts in the Wharton's jelly; 3) acute (but not chronic) chorioamnionitis was associated with the presence of IL-33+ macrophages in the chorioamniotic membranes and umbilical cord; 4) expression of IL-33 or IL1RL1 (ST2) mRNA in AECs was undetectable; 5) IL-33 mRNA expression increased in AMCs and HUVECs after IL-1β treatment but did not change with CXCL10 treatment; and 6) IL1RL1 (ST2) expression decreased in AMCs and increased in HUVECs after IL-1β but not CXCL10 treatment.

Conclusions: IL-33 is expressed in the nucleus of placental endothelial cells, CD14+ macrophages, and myofibroblasts in the Wharton's jelly. IL-1β can induce the expression of IL-33 and its receptor. Protein expression of IL-33 is detectable in macrophages of the chorioamniotic membranes in acute (but not chronic) chorioamnionitis.

Publication types

  • Research Support, N.I.H., Intramural

MeSH terms

  • Acute Disease
  • Amnion / blood supply
  • Amnion / chemistry
  • Cell Nucleus / chemistry
  • Chorioamnionitis / metabolism
  • Chorion / blood supply
  • Chorion / chemistry
  • Chronic Disease
  • Cross-Sectional Studies
  • Endothelial Cells / chemistry
  • Female
  • Humans
  • Interleukin-1 Receptor-Like 1 Protein
  • Interleukin-33
  • Interleukins / analysis*
  • Interleukins / genetics
  • Labor, Obstetric / metabolism
  • Lipopolysaccharide Receptors / analysis
  • Macrophages / chemistry
  • Macrophages / ultrastructure
  • Mesenchymal Stem Cells / ultrastructure
  • Obstetric Labor, Premature / metabolism
  • Placenta / chemistry*
  • Pregnancy
  • RNA, Messenger / analysis
  • Receptors, Cell Surface / analysis
  • Receptors, Cell Surface / genetics
  • Umbilical Veins / chemistry

Substances

  • IL1RL1 protein, human
  • IL33 protein, human
  • Interleukin-1 Receptor-Like 1 Protein
  • Interleukin-33
  • Interleukins
  • Lipopolysaccharide Receptors
  • RNA, Messenger
  • Receptors, Cell Surface